Renovaro Inc. (RENB) Short-Term Debt to Equity

Graphic logo of Renovaro Inc. (RENB)

Renovaro Inc. (RENB) is developing AI technologies and biotech solutions for early tumor detection, leveraging long-term patents and support from global pharma behemoths. This price action chart on the GURU.Markets platform reflects the 0.07 indicator. The business is scaling cell therapy through algorithms, which accelerates the search for formulas and paves the way for high-margin mass production of medications in the future.

RENB - Renovaro Inc. Short-Term Debt to Equity Ratio over the range 02/21/2024 - 10/01/2025

Financial and market metric breakdowns for Enochian BioSciences (RENB)

- stock quotes and analyst forecast:
Stock Price Renovaro Inc.|RENB - Analyst Consensus Forecast
- market capitalization details:
Market Value Renovaro Biosciences|RENB - Business Value
- balance sheet equity data:
Book Value per Share Renovaro|RENB - Company Net Assets|Market Capitalization to Book Value Ratio renovarobio.com|RENB - Company Assets
- business debt structure and liquidity details:
Debt to Equity Renovaro Inc.|RENB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Renovaro Inc.|RENB - Aggregate Debt Obligations|Debts to Book Capitalization Renovaro Biosciences|RENB - Company Long-Term Liabilities|Company Current Liabilities Renovaro|Quick Liquidity renovarobio.com
- earnings and market ratios statistics:
RENB - Final Profit
Fundamental valuation:Renovaro
Signature product of renovarobio.com

To assess the resilience of Renovaro Inc. (RENB) within the capital-intensive AI immunotherapy sector, it is critical to compare short-term liabilities against equity. This metric determines the startup's reliance on quick loans to fund the salaries of high-paid researchers, while the current short-term debt to equity ratio signals either the presence of a liquid reserve or the risk of a funding shortfall for the execution of its medical mission.

Competitors of Renovaro Inc.

Short-Term Debt to Capital ONC|Short-Term Debt to Capital Halozyme Corp (HALO)|Short-Term Debt to Equity Revolution Medicines RVMD|AAPG: Short-Term Debt to Capital Ratio|CG Oncology - Short-Term Debt to Capital|UroGen Pharma Ltd (URGN) - Short-Term Debt to Equity Ratio|BCAX: Short-Term Debt to Capital|Current Liabilities to Capital Personalis Genomics (PSNL)|Short-Term Debt to Equity Erasca, Inc.|DCTH: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio YMAB (Y-mAbs Therapeutics, Inc.)|AURA (Aura Biosciences Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CADL (Candel Therapeutics, Inc.)|ARAY - Short-Term Debt to Equity Ratio|SLS: Short-Term Debt to Equity Ratio|ACTU - Short-Term Debt to Capital|Citius Oncology (CTOR) - Short-Term Debt to Equity|TuHURA Biosciences - Ratio of Short-Term Indebtedness to Capital|TARA (Protara) - Short-Term Debt to Capital|Current Liabilities to Capital Fate Pharma FATE|Short-Term Debt to Equity Aadi Bioscience Inc (WHWK)|TCRX (tscan.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CSBR (Champions Oncology, Inc.)|XBiotech Inc (XBIT) - Current Liabilities to Capital|CVM - Short-Term Debt to Equity|OSTX (OS Therapies, Inc.) - Short-Term Debt to Capital Ratio|Radiopharm Theranostics (RADX) - Short-Term Debt to Equity|Current Liabilities to Capital Artiva Biotherapeutics (ARTV)|Short-Term Debt to Equity Ratio ANL|Short-Term Debt to Equity VERU|Short-Term Debt to Capital TPST|Short-Term Debt to Capital xiliotx.com (XLO)|Short-Term Debt to Equity Mural Oncology MURA|Ratio of Short-Term Indebtedness to Capital KAPA|OKUR - Short-Term Debt to Equity|Current Liabilities to Capital CytoMed Therapeutics|CRIS (curis.com) - Short-Term Debt to Equity Ratio|Apollomics - Ratio of Short-Term Indebtedness to Capital|THAR (Tharimmune, Inc.) - Short-Term Debt to Capital|Advanced Biomed Corp (ADVB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Genprex (GNPX)|calidibio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital SBFM (Sunshine Biopharma)|XBIO - Short-Term Debt to Equity Ratio|SLRX: Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient purple-biotech.com PPBT|aoncology.com (AONC) - Short-Term Debt to Equity|BeiGene Ltd. - Ratio of Short-Term Indebtedness to Capital|CKPT (Checkpoint Therapeutics, Inc) - Short-Term Debt to Capital|Current Liabilities to Capital Elevation Oncology Inc. ELEV|Short-Term Debt to Equity iCAD, Inc. (ICAD)|ikenaoncology.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital NTBL (Notable Labs)|Viracta Therapeutics Inc. - Short-Term Debt to Equity|MorphoSys Corp - Short-Term Debt to Capital|NAYA Biosciences Corp (NAYA) - Short-Term Debt to Equity Ratio|AAPGV: Short-Term Debt to Capital